Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.
about
A chemical analog of curcumin as an improved inhibitor of amyloid Abeta oligomerizationLow molecular weight oligomers of amyloid peptides display beta-barrel conformations: a replica exchange molecular dynamics study in explicit solvent.A survey of the different roles of polyoxometalates in their interaction with amino acids, peptides and proteins.Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative.Untapped ethical resources for neurodegeneration research.Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?Regional rescue of spinocerebellar ataxia type 1 phenotypes by 14-3-3epsilon haploinsufficiency in mice underscores complex pathogenicity in neurodegenerationS14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.Amyloid beta-protein assembly and Alzheimer disease.Discovery of DNA dyes Hoechst 34580 and 33342 as good candidates for inhibiting amyloid beta formation: in silico and in vitro study.Synthesis and biological evaluation of 1, 3-dihydroxyxanthone mannich base derivatives as anticholinesterase agents.Low-n oligomers as therapeutic targets of Alzheimer's disease.Alzheimer's disease Aβ assemblies mediating rapid disruption of synaptic plasticity and memory.The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's diseaseNanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles.Co-assembly of polyoxometalates and peptides towards biological applications.Polyoxometalates as inhibitors of the aggregation of amyloid β peptides associated with Alzheimer's disease.Neuroprotective Effects of Biochanin A against β-Amyloid-Induced Neurotoxicity in PC12 Cells via a Mitochondrial-Dependent Apoptosis Pathway.Identification of small-molecule binding pockets in the soluble monomeric form of the Aβ42 peptide.HtrA1 Proteolysis of ApoE In Vitro Is Allele Selective.Using Multifunctional Peptide Conjugated Au Nanorods for Monitoring β-amyloid Aggregation and Chemo-Photothermal Treatment of Alzheimer's Disease.BRICHOS domains efficiently delay fibrillation of amyloid β-peptide.Hematite-Based Photoelectrode Materials for Photoelectrocatalytic Inhibition of Alzheimer's β-Amyloid Self-Assembly.Self-assembled peptide-polyoxometalate hybrid nanospheres: two in one enhances targeted inhibition of amyloid β-peptide aggregation associated with Alzheimer's disease.Binding of fullerenes to amyloid beta fibrils: size matters.Acute Exposure of the Mediobasal Hypothalamus to Amyloid-β25-35 Perturbs Hepatic Glucose Metabolism.Amyloid β-protein suppressed nicotinic acetylcholine receptor-mediated currents in acutely isolated rat hippocampal CA1 pyramidal neurons.Colivelin ameliorates amyloid β peptide-induced impairments in spatial memory, synaptic plasticity, and calcium homeostasis in rats.Selenomethionine Attenuates the Amyloid-β Level by Both Inhibiting Amyloid-β Production and Modulating Autophagy in Neuron-2a/AβPPswe Cells.Graphene quantum dots for the inhibition of β amyloid aggregation.Morphology-Specific Inhibition of β-Amyloid Aggregates by 17β-Hydroxysteroid Dehydrogenase Type 10.
P2860
Q28481562-27EF4880-F78A-4AA9-A5C2-89355F4162FFQ30156880-BBE15942-775D-4A86-AA48-372C45809F39Q30402287-021EF68C-788A-4B55-90A4-1637628AFF09Q33794509-29D51BEB-407D-4744-88CB-D2C1E6B95690Q33920336-A1704448-2F78-4BBC-B221-F0B32FAB55EBQ34322386-09865786-E451-4955-9BC6-C197F560BFB4Q34549833-F908B8DA-1836-4E9E-8B81-35BC47DB8527Q34561747-800BB888-8343-4C72-AC9B-35C4F20CD241Q34849544-EF8E30A7-A223-4763-B18F-23AAE1C514A2Q36100810-CE125CCE-659C-4AC9-80F0-D1A664871426Q36905746-9E736F20-3C34-4070-A644-92E80BACA4A5Q37829762-C8195047-5A85-4941-B5D0-880AA4943EA0Q38026984-43BEBA2D-2CCC-46FC-8730-A93DD5FFF41CQ38061633-DC80D736-915F-45D9-ABDC-574CA643A834Q38809142-6BB420AF-37B9-4C83-BD86-CAB3868602EBQ38809381-A013D249-419C-4625-996A-66A311014BF1Q39571412-94299054-FE0F-4342-AA86-2A5DB03645E5Q39817198-8DC6A468-4C35-42EC-B75E-936236F64483Q41015632-8A32D6E2-05EC-44B2-B341-7ABA6FBF65C2Q41455388-BFC5203C-0B55-438E-9C01-34FBB959F79EQ41481527-08C46E42-B87B-4FA6-8466-415B122E40E6Q41856638-455B826B-6FE5-4BB0-BDA6-77B3F910ACEAQ46418238-17A933AD-7915-4FCC-890B-2A097213998AQ46466132-5C6297F1-8629-4B3B-A40F-672743766729Q47442457-3A12A5F2-6091-4119-AB74-F4C7E7644207Q48231708-3FDCEE55-F414-4569-B926-AB0618547CAFQ48362099-AD1AAB78-DFDF-4136-BC35-7A0AC23C3DE2Q48479319-1D23393D-CBC7-440C-AC0B-4B6E41577D98Q51194848-1923B3AE-57A2-434F-8876-E0179C9E1FAEQ51666359-CD128442-FB10-4257-83F0-B4BC4C9D18A6Q53143766-8786D6FB-2B55-4F1A-9E07-E4A82D02F234
P2860
Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.
@ast
Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.
@en
type
label
Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.
@ast
Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.
@en
prefLabel
Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.
@ast
Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.
@en
P2093
P2860
P1476
Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.
@en
P2093
David B Teplow
Ghiam Yamin
Kenjiro Ono
P2860
P304
P356
10.2174/138161208786404137
P577
2008-01-01T00:00:00Z